語言

Dr. Chi-Huey Wong Honored as 2022 Recipient of the Tetrahedron Prize

Original Content Source : Academia Sinica News

 

Elsevier and the Board of Executive Editors of Elsevier’s Tetrahedron journal series has announced Academician Chi-Huey Wong as the recipient of the 2022 Tetrahedron Prize for Creativity in Organic Synthesis, in honor of his outstanding contributions in organic synthesis research. Dr. Wong is the first scholar from Taiwan to receive this award.

According to Elsevier’s announcement, Dr. Wong is best known for his work on chemo-enzymatic and programmable synthesis of oligosaccharides and glycoproteins, elucidation of glycosylation effect on protein folding and function, and development of glycan microarrays, universal vaccines and homogeneous antibodies against influenza, SARS-CoV-2, and cancer.

Dr. Wong said “I am deeply honored to receive the Tetrahedron Prize this year. It is a recognition of our long-time research in the field of glycoscience. I am most grateful to the coworkers and collaborators for their contributions to make this recognition possible, also to Scripps Research, Academia Sinica, and the organizations that support our research, and to the nominator and the selection committee for giving me this honor. This prize is particularly meaningful to me as I had a wonderful experience with the Tetrahedron Publications when serving as Chairman of the Board of Editors years ago.”

The Tetrahedron Prize is awarded on an annual basis for creativity in Organic Chemistry or Bioorganic & Medicinal Chemistry. It is awarded to a chemist who has made significant original contributions to the field, in its broadest sense.

Tetrahedron Prize for Creativity in Organic Synthesis— 2022 Winner Announced: https://www.journals.elsevier.com/tetrahedron/awards/tetrahedron-prize-for-creativity-in-organic-synthesis-2022-winner-announced 

LATEST NEWS

  • The Next Chapter of Precision Chemical Modification: From Natural Product Inspirations to Efficient Drugs for Rare Disease +

    Read More
  • Sulfated Disaccharides Repair Toxic Protein Gain-of-Function, a New Approach to Treatment of Amyotrophic Lateral Sclerosis +

    Read More
  • Unveiling the Mystery of Cancer-Causing KRAS Gene Driving Pancreatic Precancerous Lesions +

    Read More
  • Unveiling Antigen Presentation and Cross-reactive Antibody Response of an Oligosaccharide-conjugate Vaccine, Paving the Way for Advanced Cancer Vaccines +

    Read More
  • Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc +

    Read More
  • 1
  • 2